XML 33 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows
¥ in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2022
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
CNY (¥)
Mar. 31, 2020
CNY (¥)
Cash flows from operating activities:        
Net loss ¥ (132,823) $ (20,954) ¥ (193,216) ¥ (175,933)
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization expense 7,678 1,211 7,083 4,588
Provision for inventories 311 49 (8) 273
Provision for doubtful accounts 213 34 (107) 271
Interest expense of other debts 17,144 2,704 21,611 53,934
Interest receivable for issuance of ordinary shares (14,239) (2,246) (15,394)  
Amortization of right-of-use assets 11,705 1,846 11,687 15,708
Interest of lease liabilities 1,949 307 1,596 1,353
Investment income 622 98    
Share of results of equity investees (418) (66) 131 520
Loss/(gain) on disposal of property and equipment (104) (16) 20 31
Gain on disposal of other debts     (6,846) (10,095)
Gain from the re-measurement of the previously held equity interest to the fair value in the business acquisition (127) (20)   (481)
Share-based compensation expense 14,409 2,273 55,022  
Fair value change of derivative liabilities (2,824) (445) (11,369) (13,345)
Deferred tax expense (989) (156) (1,889) (661)
Changes in operating assets and liabilities, net of effects of businesses acquired:        
Accounts receivable (6,131) (967) (880) (16,010)
Inventories (23,176) (3,656) (38,839) 15,486
Prepayments and other current assets (35,056) (5,530) (48,853) 3,331
Amounts due from related parties 490 77 (2,663) (1,944)
Operating lease liabilities (12,849) (2,027) (12,850) (18,183)
Accounts payable 18,106 2,856 (22,029) (19,535)
Salary and welfare payable 293 46 2,518 355
Accrued liabilities and other current liabilities 1,954 308 667 574
Amounts due to related parties (808) (127) 1,062 (105)
Contract liabilities 3,140 495 (5,229) 1,887
Other non-current assets 4,026 635 11,289 (7,931)
Net cash used in operating activities (147,504) (23,271) (247,486) (165,912)
Cash flows from investing activities:        
Loan receivables advanced to a third party (2,376) (375) (49,392) (37,671)
Repayments on loan receivables from a third party 2,579 407 44,840 12,013
Loan receivables advanced to a related party (35,995) (5,678) (4,814)  
Repayments on loan receivables from a related party 35,245 5,560    
Acquisition of subsidiaries, net of cash and cash equivalents acquired       1,783
Increase/(decrease) in short-term investments 40,462 6,383 (168,546)  
Purchase of intangible assets (24) (4)   (2)
Purchase of property and equipment (3,077) (485) (6,509) (1,204)
Disposal of property and equipment 125 20 4 5
Acquisitions of long-term investments (15,792) (2,491)   (50,000)
Disposal of equity investees       20
Net cash generated from/ (used in) investing activities 21,147 3,337 (184,417) (75,056)
Cash flows from financing activities:        
Proceeds from issuance of convertible redeemable preferred shares, net of issuance costs     354,825 41,197
Acquisition of additional interests in subsidiaries from non-controlling interests 245 39    
Proceeds from short-term and long-term borrowings 185,614 29,280 87,846 162,501
Repayments of short-term and long-term borrowings (176,897) (27,905) (74,000) (43,533)
Proceeds from issuance of other debts, net of issuance costs     16,940 134,867
Proceeds from issuance of ordinary shares 262,870 41,467    
Repayments of other debts (270,860) (42,727) (130,827)  
Proceeds from exercise of share option 1,023 161 9  
Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid     393,698  
Net cash flows generated from financing activities 1,995 315 648,491 295,032
Net increase (decrease) in cash, cash equivalents and restricted cash (124,362) (19,619) 216,588 54,064
Cash, cash equivalents and restricted cash at beginning of year 292,237 46,099 88,352 27,217
Effects of exchange rate changes on cash, cash equivalents and restricted cash (5,020) (790) (12,703) 7,071
Cash, cash equivalents and restricted cash at end of year 162,855 25,690 292,237 88,352
Supplemental schedule of non-cash investing and financing activities:        
Accretion on convertible redeemable preferred shares   120,873 (204,796)
Accretion on redeemable non-controlling interests (575) (91) (138)  
Deemed dividend to preferred shareholders     (12,547) (1,142)
Non-cash consideration paid for business acquisitions       (33,440)
Unpaid cash consideration for business acquisitions (2,938) (463)    
Additional ASC 842 supplemental disclosure:        
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities 12,849 2,027 12,850 18,183
Right-of-use assets obtained in exchange for operating lease obligations ¥ 21,038 $ 3,319 ¥ 25,970 ¥ 10,051